As soon as he heard that, Bach, who has been documenting the dizzying rise of cancer-drug prices since 2009, immediately jumped into an elevator to go to Saltz’s office to learn more about the unprecedented decision. Why the rush? “C’mon!” Bach explained to me recently. “It’s never happened before! Sloan-Kettering isn’t including a drug because of its price?”
Thus began the first physician-initiated revolt in anyone’s memory against the skyrocketing cost of cancer drugs.
–Stephen Hall, NY Magazine (h/t Brad Flansbaum)
@afrakt (via phone)
